These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38561958)

  • 1. Cannabidiol use in France in 2022: Results from a nationwide representative sample of adults.
    Barré T; Lahaie E; Di Beo V; Carrieri P; Andler R; Nguyen-Thanh V; Beck F
    Drug Alcohol Rev; 2024 Jul; 43(5):1294-1304. PubMed ID: 38561958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol use and perceptions in France: a national survey.
    Casanova C; Ramier C; Fortin D; Carrieri P; Mancini J; Barré T
    BMC Public Health; 2022 Aug; 22(1):1628. PubMed ID: 36038869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recreational Cannabidiol: Awareness, Prevalence of use, and Associated Factors in a Representative Sample of the German Population.
    Alayli AFG; Kotz D; Kastaun S
    Subst Use Misuse; 2022; 57(9):1417-1424. PubMed ID: 35686726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents.
    Dai HD; Subramanian R; Mahroke A; Wang M
    JAMA Netw Open; 2023 Aug; 6(8):e2329167. PubMed ID: 37585202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021.
    Geppert J; Lietzow J; Hessel-Pras S; Kirsch F; Schäfer B; Sachse B
    BMC Public Health; 2023 Nov; 23(1):2318. PubMed ID: 37996800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2022 Jan; 23(1):45-54. PubMed ID: 34214700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
    Dunbar MS; Seelam R; Tucker JS; Firth CL; Pedersen ER; Klein DJ; Rodriguez A; D'Amico EJ
    Addict Behav; 2022 Mar; 126():107185. PubMed ID: 34839070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults.
    Wheeler M; Merten JW; Gordon BT; Hamadi H
    Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530
    [No Abstract]   [Full Text] [Related]  

  • 10. A "Good" Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use.
    Fortin D; Di Beo V; Massin S; Bisiou Y; Carrieri P; Barré T
    Front Psychiatry; 2022; 13():829944. PubMed ID: 35370865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
    Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
    Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, modes of administration and motives for cannabidiol use in young Swiss men.
    Bertholet N; Marmet S; Wicki M; Gmel G; Studer J
    Swiss Med Wkly; 2021 Dec; 151():w30054. PubMed ID: 34964581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a brand-specific, hemp-derived cannabidiol product on physiological, biochemical, and psychometric outcomes in healthy adults: a double-blind, randomized clinical trial.
    Mastrofini GF; McFadden BA; Chandler AJ; Lints BS; Cintineo HP; Rhoades ND; Vincenty CS; Stray-Gundersen SO; Lane AD; Arent SM
    J Int Soc Sports Nutr; 2024 Dec; 21(1):2370430. PubMed ID: 38904150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Naftali T; Mechulam R; Marii A; Gabay G; Stein A; Bronshtain M; Laish I; Benjaminov F; Konikoff FM
    Dig Dis Sci; 2017 Jun; 62(6):1615-1620. PubMed ID: 28349233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.
    Szaflarski JP; Hernando K; Bebin EM; Gaston TE; Grayson LE; Ampah SB; Moreadith R
    Epilepsy Behav; 2019 Jun; 95():131-136. PubMed ID: 31048098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.
    Elms L; Shannon S; Hughes S; Lewis N
    J Altern Complement Med; 2019 Apr; 25(4):392-397. PubMed ID: 30543451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with ever using cannabidiol in a cohort of younger pregnant people.
    De Genna NM; Kennon-McGill S; Goldschmidt L; Richardson GA; Chang JC
    Neurotoxicol Teratol; 2023; 96():107162. PubMed ID: 36717004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.